| Sildenafil |
II-6425/09.12.2009 |
Vigrande, Film coated tablet, 100 mg, -, Pack: 1 |
Zentiva a.s., Словакия |
Zentiva a.s. Slovak Republic |
8.92 |
1.78 |
10.7 |
7% |
0.62 |
9.54 |
1.91 |
11.45 |
20% |
1.78 |
11.32 |
2.26 |
13.58 |
КЦ-1385/
12,02,2010 г. |
01.03.2010 |
01.03.2010 |
Цената е заличена с решение НСР-2674/03.02.2014 |
|
Заличен |
7765 |
| Sildenafil |
II-6424/09.12.2009 |
Vigrande, Film coated tablet, 50 mg, -, Pack: 4 |
Zentiva a.s., Словакия |
Zentiva a.s. Slovak Republic |
29.57 |
5.91 |
35.48 |
6% |
1.77 |
31.34 |
6.27 |
37.61 |
18% |
5.32 |
36.66 |
7.33 |
43.99 |
КЦ-1385/
12,02,2010 г. |
01.03.2010 |
01.03.2010 |
Цената е заличена с решение НСР-2673/03.02.2014 |
|
Заличен |
7764 |
| Sildenafil |
II-6424/09.12.2009 |
Vigrande, Film coated tablet, 50 mg, -, Pack: 1 |
Zentiva a.s., Словакия |
Zentiva a.s. Slovak Republic |
7.59 |
1.52 |
9.11 |
7% |
0.53 |
8.12 |
1.62 |
9.74 |
20% |
1.52 |
9.64 |
1.93 |
11.57 |
КЦ-1385/
12,02,2010 г. |
01.03.2010 |
01.03.2010 |
Цената е заличена с решение НСР-2673/03.02.2014 |
|
Заличен |
7763 |
| elosulfase alfa |
EU/1/14/914/001 |
Vimizim, Concentrate for solution for infusion, 1 mg/ml - 5 ml, -, Pack: 1 |
BioMarin Europe Limited, Обединено Кралство |
BioMarin Pharmaceutical Inc., USA BioMarin International Limited, Ireland |
1515.77 |
303.15 |
1818.92 |
4% |
10 |
1525.77 |
305.15 |
1830.92 |
16% |
25 |
1550.77 |
310.15 |
1860.92 |
НСР-13871/25.09.2017; НСР-19900/30.09.2019 - Предварително изпълнение |
10.10.2017 |
02.10.2019 |
|
|
Заличен |
15871 |
| elosulfase alfa |
EU/1/14/914/001 |
Vimizim, Concentrate for solution for infusion, 1 mg/ml - 5 ml, -, Pack: 1 |
BioMarin Europe Limited, Обединено Кралство |
BioMarin Pharmaceutical Inc., USA BioMarin International Limited, Ireland |
1515.77 |
303.15 |
1818.92 |
4% |
10 |
1525.77 |
305.15 |
1830.92 |
16% |
25 |
1550.77 |
310.15 |
1860.92 |
НСР-13871/25.09.2017 |
10.10.2017 |
02.11.2017 |
|
|
Неактивен |
15871 |
| Naproxen and esomeprazole |
№ ІІ - 11736/13.01.2011 |
VIMOVO, Modified release tablet, 500 mg/20 mg, -, Pack: 6 |
AstraZeneca AB, Швеция |
Astra Zeneca AB Gartunavagen SE-151 85 Sodertalje, Швеция Patheon Pharmaceuticals Inc.,2110 E Galbraith Road, Cincinati, OH 45237, USA Astra Zeneca Pharmaceuticals LP, 587 Old Baltimore Pike, Newark, DE 19702, USA |
7.04 |
1.41 |
8.45 |
7% |
0.49 |
7.53 |
1.51 |
9.04 |
20% |
1.41 |
8.94 |
1.79 |
10.73 |
КЦ-2144/20.04.2011 г. |
04.05.2011 |
04.05.2011 |
|
|
Активен |
7968 |
| Naproxen and esomeprazole |
№ ІІ - 11736/13.01.2011 |
VIMOVO, Modified release tablet, 500 mg/20 mg, -, Pack: 30 |
AstraZeneca AB, Швеция |
Astra Zeneca AB Gartunavagen SE-151 85 Sodertalje, Швеция Patheon Pharmaceuticals Inc.,2110 E Galbraith Road, Cincinati, OH 45237, USA Astra Zeneca Pharmaceuticals LP, 587 Old Baltimore Pike, Newark, DE 19702, USA |
20.54 |
4.11 |
24.65 |
6% |
1.23 |
21.77 |
4.35 |
26.12 |
18% |
3.7 |
25.47 |
5.09 |
30.56 |
КЦ-2144/20.04.2011 г. |
04.05.2011 |
04.05.2011 |
|
|
Активен |
7969 |
| Lacosamide |
EU/1/08/470/018 |
VIMPAT, Syrup, 10 mg/ml-200 ml, -, Pack: 1 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
42.07 |
8.41 |
50.48 |
4% |
1.68 |
43.75 |
8.75 |
52.5 |
16% |
6.73 |
50.48 |
10.1 |
60.58 |
НСР-17673/02.01.2019 |
17.01.2019 |
02.02.2019 |
|
|
Активен |
16403 |
| Vinorelbine |
II-15561/29.12.2006 |
VINORELBIN ACTAVIS, Concentrate for solution for infusion, 10 mg/ml, -, Pack: 1 |
Актавис EАД, България |
S.C.Sindan-Pharma S.R.L.,Romania |
40 |
8 |
48 |
4% |
1.6 |
41.6 |
8.32 |
49.92 |
16% |
6.4 |
48 |
9.6 |
57.6 |
КЦ-70/
04,06,2008 г. |
25.06.2008 |
25.06.2008 |
пределната цена е заличена с Решение КЦРР-2093/25.01.2013 г. |
|
Заличен |
7910 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml, -, Pack: 1 ml x 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
12.32 |
2.46 |
14.78 |
6% |
0.74 |
13.06 |
2.61 |
15.67 |
18% |
2.22 |
15.28 |
3.06 |
18.34 |
НСР-2578/24.01.2014 |
12.02.2014 |
12.02.2014 |
|
|
Активен |
2359 |
| Vinpocetine |
20140276 |
Vinpex, Tablet, 10, mg, Pack: 30 |
UAB Aconitum, Литва |
UAB Aconitum, Литва |
7.63 |
1.53 |
9.16 |
7% |
0.53 |
8.16 |
1.63 |
9.79 |
20% |
1.53 |
9.69 |
1.94 |
11.63 |
НСР-17847/30.01.2019 |
14.02.2019 |
02.03.2019 |
|
|
Активен |
16418 |
| Vinpocetine |
20140276 |
Vinpex, Tablet, 10, mg, Pack: 90 |
UAB Aconitum, Литва |
UAB Aconitum, Литва |
22.88 |
4.58 |
27.46 |
6% |
1.37 |
24.25 |
4.85 |
29.1 |
18% |
4.12 |
28.37 |
5.67 |
34.04 |
НСР-17846/30.01.2019 |
14.02.2019 |
02.03.2019 |
|
|
Активен |
16419 |
| Alogliptin, metformin |
EU/1/13/ 843/006 |
Vipdomet, Film coated tablet, 12.5 mg/850 mg, -, Pack: 60 |
Takeda Pharma A/S, Дания |
Takeda Ireland Limited, Ирландия |
73.93 |
14.79 |
88.72 |
4% |
2.96 |
76.89 |
15.38 |
92.27 |
16% |
11.83 |
88.72 |
17.74 |
106.46 |
НСР-4109/10.07.2014 |
25.07.2014 |
25.07.2014 |
|
|
Активен |
8895 |
| Alogliptin, metformin |
EU/1/13/ 843/018 |
Vipdomet, Film coated tablet, 12.5 mg/1000 mg, -, Pack: 60 |
Takeda Pharma A/S, Дания |
Takeda Ireland Limited, Ирландия |
73.93 |
14.79 |
88.72 |
4% |
2.96 |
76.89 |
15.38 |
92.27 |
16% |
11.83 |
88.72 |
17.74 |
106.46 |
НСР-4109/10.07.2014 |
25.07.2014 |
25.07.2014 |
|
|
Активен |
8896 |
| Alogliptin |
EU/1/13/ 844/022 |
Vipidia, Film coated tablet, 25 mg, -, Pack: 30 |
Takeda Pharma A/S, Дания |
Takeda Ireland Limited, Ирландия |
73.34 |
14.67 |
88.01 |
4% |
2.93 |
76.27 |
15.25 |
91.52 |
16% |
11.73 |
88 |
17.6 |
105.6 |
НСР-4107/10.07.2014 |
25.07.2014 |
25.07.2014 |
корекц. Решение НСР-4196/30.07.2014 |
|
Активен |
8892 |
| Alogliptin |
EU/1/13/ 844/013 |
Vipidia, Film coated tablet, 12,5 mg, -, Pack: 30 |
Takeda Pharma A/S, Дания |
Takeda Ireland Limited, Ирландия |
73.34 |
14.67 |
88.01 |
4% |
2.93 |
76.27 |
15.25 |
91.52 |
16% |
11.73 |
88 |
17.6 |
105.6 |
НСР-4107/10.07.2014 |
25.07.2014 |
25.07.2014 |
корекц. Решение НСР-4196/30.07.2014 |
|
Активен |
8891 |
| Tromantadine |
9700452 |
Viru-Merz, Gel, 10 mg/g - 2 g, -, Pack: 1 |
Merz Pharmaceuticals GmbH, Германия |
Merz Pharma GmbH & Co. KGaA |
4.26 |
0.85 |
5.11 |
7% |
0.3 |
4.56 |
0.91 |
5.47 |
20% |
0.85 |
5.41 |
1.08 |
6.49 |
НСР-1262/25.09.2013; НСР-19852/20.09.2019 |
10.10.2013 |
02.11.2019 |
|
|
Заличен |
8461 |
| Tromantadine |
9700452 |
Viru-Merz, Gel, 10 mg/g - 2 g, -, Pack: 1 |
Merz Pharmaceuticals GmbH, Германия |
Merz Pharma GmbH & Co. KGaA |
4.26 |
0.85 |
5.11 |
7% |
0.3 |
4.56 |
0.91 |
5.47 |
20% |
0.85 |
5.41 |
1.08 |
6.49 |
НСР-1262/25.09.2013 |
10.10.2013 |
10.10.2013 |
|
|
Неактивен |
8461 |
| Inosine pranobex |
20190241 |
Viruprinol, Syrup, 50 mg/ml-120 ml, -, Pack: 1 |
ДАНСОН-БГ ООД, България |
Ветпром АД |
15 |
3 |
18 |
6% |
0.9 |
15.9 |
3.18 |
19.08 |
18% |
2.7 |
18.6 |
3.72 |
22.32 |
НСР-20308/05.12.2019 |
20.12.2019 |
02.01.2020 |
|
|
Активен |
16808 |
| Dienogest |
20100101 |
Visanne, Tablet, 2 mg, -, Pack: 28 |
Bayer Pharma AG, Германия |
Bayer Weimar GmbH und Co.KG |
58.13 |
11.63 |
69.76 |
4% |
2.33 |
60.46 |
12.09 |
72.55 |
16% |
9.3 |
69.76 |
13.95 |
83.71 |
НСР-5199/04.12.2014 г.; НСР-9866/21.07.2016 |
02.09.2016 |
02.09.2016 |
|
|
Заличен |
3192 |
| Dienogest |
20100101 |
Visanne, Tablet, 2 mg, -, Pack: 28 |
Bayer Pharma AG, Германия |
Bayer Weimar GmbH und Co.KG |
58.13 |
11.63 |
69.76 |
4% |
2.33 |
60.46 |
12.09 |
72.55 |
16% |
9.3 |
69.76 |
13.95 |
83.71 |
НСР-5199/04.12.2014 г. |
02.01.2015 |
02.01.2015 |
|
|
Неактивен |
3192 |
| Iodixanol |
ІІ-14561/19.10.2006 |
Visipaque, Solution for injection, 320 mg I/ ml - 50 ml, -, Pack: 10 |
GE Healthcare AS, Норвегия |
GE Healthcare AS; GE Healthcare Ireland |
196.89 |
39.38 |
236.27 |
4% |
7.88 |
204.77 |
40.95 |
245.72 |
16% |
25 |
229.77 |
45.95 |
275.72 |
НСР-4688/25.09.2014 |
16.10.2014 |
16.10.2014 |
корекц. Решение НСР-4767/13.10.2014. |
|
Активен |
1748 |
| Iodixanol |
ІІ-14561/19.10.2006 |
Visipaque, Solution for injection, 320 mg I/ ml - 20 ml, -, Pack: 10 |
GE Healthcare AS, Норвегия |
GE Healthcare AS; GE Healthcare Ireland |
115.94 |
23.19 |
139.13 |
4% |
4.64 |
120.58 |
24.12 |
144.7 |
16% |
18.55 |
139.13 |
27.83 |
166.96 |
НСР-4688/25.09.2014 |
16.10.2014 |
16.10.2014 |
|
|
Активен |
1747 |
| Botulinum Toxin Type A |
ІІ-2405/03.07.2008 |
Vistabel, Powder for solution for injection, 4 Allergan Units/0.1 ml x 1, -, Pack: 50 Units 1 |
Allergan Pharmaceuticals, Ирландия |
Allergan Pharmaceuticals Ireland Castlebar Road Westport Co. Mayo Ирландия |
259.4 |
51.88 |
311.28 |
4% |
10 |
269.4 |
53.88 |
323.28 |
16% |
25 |
294.4 |
58.88 |
353.28 |
КЦ-1094/
13,08,2009 г. |
27.08.2009 |
27.08.2009 |
|
|
Активен |
8012 |
| Retinol palmitate |
20010581 |
VITAMIN A SOPHARMA, Oral drops, solution, 40000 IU/ml - 5 ml, -, Pack: 1 |
Софарма АД, България |
Софарма АД България |
1.75 |
0.35 |
2.1 |
7% |
0.12 |
1.87 |
0.37 |
2.24 |
20% |
0.35 |
2.22 |
0.44 |
2.66 |
НСР-907/09.08.2013 |
04.09.2013 |
04.09.2013 |
|
|
Активен |
8377 |